Rosalia Bertorelli Selected Research

Galantamine (Galanthamine)

1/2012

Synergistic effects of galantamine and memantine in attenuating scopolamine-induced amnesia in mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Rosalia Bertorelli Research Topics

Disease

11	Pain (Aches) 02/2014 - 08/2002
6	Wounds and Injuries (Trauma) 02/2022 - 06/2017
6	Hyperalgesia 03/2013 - 06/2002
5	Chronic Pain 12/2012 - 02/2005
5	Neuralgia (Stump Neuralgia) 02/2012 - 06/2002
3	Burns 01/2022 - 03/2016
3	Parkinson Disease (Parkinson's Disease) 07/2009 - 03/2007
2	Neoplasms (Cancer) 01/2022 - 01/2020
2	Inflammation (Inflammations) 03/2013 - 05/2012
2	Cognitive Dysfunction 01/2013 - 01/2012
2	Amnesia (Dissociative Amnesia) 01/2013 - 01/2012
2	Mental Disorders (Mental Disorder) 07/2009 - 04/2005
2	Catalepsy 02/2009 - 03/2007
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022
1	Prion Diseases (Transmissible Spongiform Encephalopathies) 01/2022
1	Melanoma (Melanoma, Malignant) 01/2022
1	Cardiovascular Diseases (Cardiovascular Disease) 07/2021
1	COVID-19 07/2021
1	Glioblastoma (Glioblastoma Multiforme) 02/2021
1	Neuroblastoma 12/2020
1	Leukemia 11/2020
1	Cystic Fibrosis (Mucoviscidosis) 10/2020
1	Down Syndrome (Down's Syndrome) 08/2020
1	Brain Diseases (Brain Disorder) 08/2020
1	Autistic Disorder (Autism) 08/2020
1	Neuroinflammatory Diseases 05/2020
1	Autism Spectrum Disorder 01/2018
1	Erythema 03/2016
1	Nociceptive Pain 02/2014
1	Alzheimer Disease (Alzheimer's Disease) 01/2013
1	Arthritis (Polyarthritis) 05/2012
1	Peripheral Nerve Injuries 05/2012

Drug/Important Bio-Agent (IBA)

6	metabotropic glutamate receptor type 1IBA 12/2012 - 04/2005
5	Pharmaceutical PreparationsIBA 01/2022 - 04/2009
4	Adenosine A2A Receptor (Adenosine A2A Receptors)IBA 07/2009 - 01/2003
2	Povidone (Crospovidone)IBA 02/2022 - 06/2017
2	AlginatesIBA 01/2022 - 03/2016
2	PoisonsIBA 11/2020 - 01/2020
2	Formaldehyde (Formol)FDA Link 02/2014 - 04/2005
2	CarrageenanIBA 03/2013 - 05/2012
2	Scopolamine (Hyoscine)FDA Link 01/2013 - 01/2012
2	Gabapentin (Neurontin)FDA LinkGeneric 05/2012 - 12/2011
2	Analgesics (Analgesic Drugs)IBA 05/2012 - 11/2011
2	Purinergic P2X7 ReceptorsIBA 12/2011 - 06/2011
2	2- (2- furanyl)- 7- (2- (4- (4- (2- methoxyethoxy)phenyl)- 1- piperazinyl)ethyl)- 7H- pyrazolo(4,3- e)(1,2,4)triazolo(1,5- c)pyrimidine- 5- amineIBA 07/2009 - 02/2009
2	pyrimidineIBA 02/2009 - 03/2007
2	Haloperidol (Haldol)FDA LinkGeneric 02/2009 - 03/2007
2	Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA 11/2007 - 04/2005
2	5- amino- 7- (2- phenylethyl)- 2- (2- furyl)pyrazolo(4,3- e)- 1,2,4- triazolo(1,5- c)pyrimidineIBA 03/2007 - 01/2003
1	Hyaluronic Acid (Hyaluronan)IBA 02/2022
1	SerpinsIBA 01/2022
1	Prion ProteinsIBA 01/2022
1	AntioxidantsIBA 01/2022
1	PrionsIBA 01/2022
1	GTP Phosphohydrolases (GTPases)IBA 01/2022
1	Free RadicalsIBA 01/2022
1	ARN22089IBA 01/2022
1	Soaps (Soap)IBA 07/2021
1	Disinfectants (Biocides)IBA 07/2021
1	LipidsIBA 02/2021
1	OxazolesIBA 12/2020
1	EnzymesIBA 11/2020
1	Chloride Channels (Chloride Channel)IBA 10/2020
1	DiureticsIBA 08/2020
1	Ellagic AcidIBA 05/2020
1	Cell Adhesion MoleculesIBA 01/2018
1	Biopolymers (Biopolymer)IBA 01/2018
1	Type 2 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 2)IBA 01/2018
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2018
1	LipopolysaccharidesIBA 01/2018
1	tyrosine receptor (receptor, tyrosine)IBA 01/2018
1	Phosphotransferases (Kinase)IBA 01/2018
1	PolymersIBA 01/2018
1	Anti-Bacterial Agents (Antibiotics)IBA 06/2017
1	Acetic Acid (Vinegar)FDA LinkGeneric 06/2017
1	methylallyl trisulfide (MATS)IBA 06/2017
1	Ciprofloxacin (Cipro)FDA LinkGeneric 06/2017
1	Sodium CompoundsIBA 03/2016
1	CytokinesIBA 03/2016
1	lavender oilIBA 03/2016
1	AcidsIBA 03/2013
1	N-acylethanolaminesIBA 03/2013
1	GW 6471IBA 03/2013
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 03/2013
1	5-phenylpentyl N- ((2S,3R)- 2- methyl- 4- oxo- oxetan- 3- yl)carbamateIBA 03/2013
1	amidaseIBA 03/2013
1	Peptides (Polypeptides)IBA 01/2013
1	memoquinIBA 01/2013
1	Amyloid beta-PeptidesIBA 01/2013
1	Nootropic Agents (Nootropics)IBA 01/2013
1	Indomethacin (Indometacin)FDA LinkGeneric 05/2012
1	URB937IBA 05/2012
1	Dexamethasone (Maxidex)FDA LinkGeneric 05/2012
1	Freund's AdjuvantIBA 05/2012
1	Memantine (Namenda)FDA Link 01/2012
1	Galantamine (Galanthamine)FDA LinkGeneric 01/2012

Therapy/Procedure

7	Ligation 03/2013 - 06/2002
2	Oral Administration 12/2020 - 05/2020
1	Drug-Eluting Stents 07/2021
1	Topical Administration 03/2013